Eurasian Medtech Reg Framework Speeds Ahead But Industry Concerns Persist
This article was originally published in The Gray Sheet
Executive Summary
The Eurasian Economic Union trade bloc is being developed to establish an economic common market across industry activities, including medicine and medical products, in the region. But medical device firms worry the process is moving too quickly without transparency.
You may also be interested in...
Eurasian Medtech System Battles To Be In Place This Year
The Eurasian Economic Union's system for regulating medtech products is dropping into place, but too slowly as some see it, and still with many questions remaining over the content. However, it remains a fixture for the future, and device companies serving the region need to be prepared.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.